Multi-Drug Resistant Tuberculosis (MDR TB) Update
New Treatment Regimens A major breakthrough in 2024 is the rollout of a new drug regimen known as BPaL, which combines bedaquiline, pretomanid, and linezolid....
web privacy check
Your browser shows every web site you visit the information below.